The Institute of Cancer Therapeutics (ICT) provides industry clients with advanced research services focused on development of cancer therapeutics ranging from drug discovery, progression of pharmacology of preclinical candidates through to clinical evaluation. Contact Head of Business Engagement Jason Jones to discuss our offer: J.R.Jones@bradford.ac.uk
Institute of Cancer Therapeutics
The Institute of Cancer Therapeutics (ICT) is a multidisciplinary team of researchers working together to research, develop and commercialise new cancer treatments.
We are one of only a few centres in the UK with the research tools and expertise in-house to progress anticancer medicines and biomarkers from concept to clinic.
Welcome from the Director
I welcome you to the Institute of Cancer Therapeutics (ICT), the home of multidisciplinary teams working together to make fundamental discoveries and take them to the clinic.
Bradford has a proud history of cancer research dating back to the 1950s, with some of the earliest clinical trials for chemotherapy in breast cancer undertaken by George Whyte-Watson and Robert Lowry-Turner at Bradford Royal Infirmary. Today in the era of precision medicine, we are focused on targeted cancer therapeutics, and are using our skills and experience in medicinal chemistry, drug discovery, preclinical pharmacology, drug metabolism and pharmacokinetics, and cell and molecular biology as we develop new treatments and diagnostics from concept to clinic.
The ICT is world-renowned for cancer research, training, and partnerships with industry. We are located in a purpose-built facility carrying over 30 years’ experience in preclinical anticancer drug development. We routinely perform laboratory analysis for ongoing cancer clinical trials principally through St James Hospital (Leeds). Our hospital links also include the Bradford Royal Infirmary and the Royal Hallamshire (Sheffield). We boast an international network of collaborators that includes Universities at Stanford, Harvard, Oxford and Cambridge.
Whether you are a commercial organisation looking for high-quality services with experienced academic input, a student seeking first-class cancer research training, or a scientist wishing to be immersed in a stimulating and nurturing environment – please get in touch: we look forward to working with you.
The Institute of Cancer Therapeutics is world-renowned for research, training and partnership with industry. Our excellence is testified by substantial investment from industry and research councils, leading to high impact outputs, innovation and knowledge transfer.
Postgraduate study at the ICT
The Institute of Cancer Therapeutics (ICT) offers a range of postgraduate courses including three well-established MSc/MRes courses and a series of PhD research projects.
Our PhD projects benefit from an excellent multi-disciplinary research environment providing expertise across a broad range of fields together with a vibrant and supportive student community. See more on our Postgraduate Study pages.
Networks and partners
The Institute of Cancer Therapeutics has many research collaborations and industry partnerships that span all our research capabilities. Some of our key research partnerships are outlined below:
- Bone Cancer Research Trust (funding)
- Breast Cancer Now (funding)
- Worldwide Cancer Research (funding)
- Neuroblastoma UK (Funding)
- Academy of Medical Sciences Springboard (funding)
- UK-India Education and Research Initiative [UKIERI] (funding)
- Masonic Charitable Foundation (funding)
- St James's University Hospital, Leeds NIHR Clinical Research Facility (Partner)
- Bradford Teaching Hospitals Foundation Trust (collaborator)
- Ethical Tissue (Spin-out)
- Incanthera plc (Spin-out)
Meet the academic team
Professor Robert Falconer
Director of the Institute of Cancer Therapeutics
Professor Chris Twelves
Honorary Professor
Professor Paul Loadman
Professor of Drug Metabolism and Pharmacokinetics
Professor Sherif El-Khamisy
Professor and PVC of Research and Innovation
Professor Klaus Pors
Professor of Chemical Biology & YCR Group Leader
Dr Richard Wheelhouse
Reader in Medicinal Chemistry
Dr Jurgen Muller
Reader in Pharmacology
Dr Steve Shnyder
Associate Professor in Tumour Biology
Dr Helen Sheldrake
Assistant Professor in Organic and Medicinal Chemistry
Dr Huw Simon Jones
Assistant Professor in Drug Metabolism and Medical Biochemistry
Dr Peter Nicholls
Assistant Professor in Molecular Biology
Dr Amalia Ruiz
Assistant Professor in Biochemistry and Pharmacology
Dr Muhammad Wahajuddin
Assistant Professor in Pharmacokinetics
Dr Sneha Swaroop
Assistant Professor in Cell and Molecular Biology
Dr. Vibhu Jha
Assistant Professor in Computational Drug Design
Dr Ethan Perkins
Lecturer in Cancer Biology & Therapeutics
Dr Goreti Ribeiro Morais
Lecturer in Medicinal Chemistry
Dr Francis Barnieh
UoB STARTER Research Fellow at the ICT
Professor Laurence Patterson
Emeritus Professor of Drug Discovery
Professor Mohamed El-Tanani
Visiting Professor
Get in touch
- Business Enquiries: j.r.jones@bradford.ac.uk
- Postgraduate Training: e.d.perkins1@bradford.ac.uk
- Postgraduate Research: S.D.Shnyder@bradford.ac.uk
Our address is:
Institute of Cancer Therapeutics
University of Bradford
Richmond Road
Bradford
West Yorkshire
United Kingdom
BD7 1DP